Understanding the link between diabetes, brain changes, and memory in middle-aged Hispanic adults
Diabetes and brain amyloid in middle aged Hispanics
This project looks at how type 2 diabetes and pre-diabetes might be connected to changes in the brain that are seen in Alzheimer's disease, especially in middle-aged Hispanic individuals.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11103283 on NIH RePORTER |
What this research studies
Researchers are exploring if having type 2 diabetes or pre-diabetes leads to more amyloid-beta protein buildup in the brain, a key sign of Alzheimer's disease. They are using special brain scans, called PET and MRI, to look at amyloid, tau, and other brain changes in a group of middle-aged Hispanic adults. The team has already found that pre-diabetes, but not full diabetes, seems linked to higher amyloid, and that diabetes treatment might help lower amyloid levels. They also observed differences in amyloid and tau between men and women, providing important insights into how these conditions affect brain health.
Who could benefit from this research
Good fit: Ideal participants for this type of research would be middle-aged Hispanic adults with or without type 2 diabetes or pre-diabetes.
Not a fit: Patients who do not have diabetes, pre-diabetes, or concerns about Alzheimer's disease may not directly benefit from this specific research.
Why it matters
Potential benefit: This work could help us better understand how diabetes affects brain health and Alzheimer's risk, potentially leading to new ways to prevent or treat memory problems.
How similar studies have performed: This project builds on previous findings from the same research team, suggesting that diabetes treatment may influence brain amyloid levels.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Luchsinger, Jose Alejandro — Columbia University Health Sciences
- Study coordinator: Luchsinger, Jose Alejandro
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.